•
Mar 31

Voyager Therapeutics Q1 2025 Earnings Report

Expected Revenue:$13.6M
+44.0% YoY
Expected EPS:-$0.44
0.0% YoY
Total Revenue
$6.47M
Previous year: $19.5M
-66.8%
Gross Profit
$5.46M
Previous year: $18.3M
-70.2%
Cash and Equivalents
$236M
Previous year: $401M
-41.1%
Free Cash Flow
-$38.6M
Previous year: $56.6M
-168.1%
Total Assets
$353M
Previous year: $470M
-24.8%

Voyager Therapeutics

Voyager Therapeutics